Vaccines: Handbook of Experimental Pharmacology, cartea 133
Editat de Peter Perlman, Hans Wigzellen Limba Engleză Paperback – 21 dec 2011
Din seria Handbook of Experimental Pharmacology
- 5% Preț: 3517.78 lei
- 5% Preț: 1425.97 lei
- 5% Preț: 1435.28 lei
- 5% Preț: 1430.52 lei
- 5% Preț: 1930.69 lei
- 5% Preț: 1922.47 lei
- 5% Preț: 1937.46 lei
- 5% Preț: 2117.58 lei
- 5% Preț: 2119.96 lei
- 5% Preț: 2117.38 lei
- 5% Preț: 1088.15 lei
- 5% Preț: 1098.27 lei
- 5% Preț: 1420.29 lei
- 5% Preț: 1104.84 lei
- 5% Preț: 1104.84 lei
- 5% Preț: 1108.14 lei
- 5% Preț: 1106.69 lei
- 5% Preț: 1105.77 lei
- 5% Preț: 1174.35 lei
- 5% Preț: 408.48 lei
- 5% Preț: 409.63 lei
- 5% Preț: 539.89 lei
- 5% Preț: 720.47 lei
- 5% Preț: 733.09 lei
- 5% Preț: 731.27 lei
- 5% Preț: 746.43 lei
- 5% Preț: 747.72 lei
- 5% Preț: 725.24 lei
- 5% Preț: 742.80 lei
- 5% Preț: 393.23 lei
- 5% Preț: 735.66 lei
- 5% Preț: 728.33 lei
- 5% Preț: 389.52 lei
- 5% Preț: 730.71 lei
- 5% Preț: 740.58 lei
- 5% Preț: 730.19 lei
- 5% Preț: 723.42 lei
- 5% Preț: 731.27 lei
- 5% Preț: 726.68 lei
- 5% Preț: 3516.49 lei
- 5% Preț: 729.26 lei
- 5% Preț: 737.11 lei
- 5% Preț: 730.92 lei
- 5% Preț: 738.78 lei
- 5% Preț: 909.94 lei
- 5% Preț: 720.10 lei
- 5% Preț: 734.74 lei
- 5% Preț: 727.80 lei
- 5% Preț: 3513.38 lei
Preț: 730.34 lei
Preț vechi: 768.78 lei
-5% Nou
Puncte Express: 1096
Preț estimativ în valută:
139.76€ • 145.03$ • 116.82£
139.76€ • 145.03$ • 116.82£
Carte tipărită la comandă
Livrare economică 17-31 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642641961
ISBN-10: 3642641962
Pagini: 564
Ilustrații: XXV, 534 p.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.78 kg
Ediția:Softcover reprint of the original 1st ed. 1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642641962
Pagini: 564
Ilustrații: XXV, 534 p.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.78 kg
Ediția:Softcover reprint of the original 1st ed. 1999
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
Professional/practitionerCuprins
1 Vaccines: Past, Present and Future.- A. Bacterial Vaccines: Past, Present and Future.- B. Viral Vaccines.- C. Parasite Vaccines.- References.- 2 Immunology of Infection.- A. Introduction.- B. The Adaptive (Acquired) Immune Response.- C. The Cellular Immune System: T Cells.- D. Cytokines.- E. The Early Decision on the Type of Effector Functions that Prevail in an Immune Response.- F. The Humoral Immune System: B Cells.- G. T and B Cell Memory.- H. Mucosal Immunity.- I. Unsuccessful Induction of Specific Immune Responses.- J. Implications for Rational Vaccine Design.- References.- 3 DNA Vaccines: Immunogenicity and Preclinical Efficacy.- A. Overview.- B. Background.- C. Effectiveness of DNA Vaccines in Animal Models.- D. Mucosal Immunization.- E. Delivery Systems and Adjuvants.- F. Summary.- References.- 4 Antigen-Presentation Systems, Immunomodulators, and Immune Responses to Vaccines.- A. From Empirical Approaches to Rationally Selected Antigen-Presentation Systems and Immunomodulators for Vaccine-Mediated Protection Against Infectious Diseases.- B. What Are the Essential Parameters of Vaccine-Induced Effector Mechanisms?.- C. What Fundamental Immunological Mechanisms Can Be Modulated by Antigen-Delivery Systems and Immunomodulators?.- D. What Is the Effect of Specific Delivery Systems and Immunomodulators on Responses to Vaccine Antigens?.- E. How Can Vaccines Be Designed for Selected Target Populations with Variable Levels of Immunocompetence?.- F. Conclusions.- References.- 5 Vaccines Against Measles, Mumps, Rubella, and Varicella.- A. Introduction.- B. Measles Vaccine.- C.) Mumps Vaccine.- D. Rubella Vaccine.- E. Varicella Vaccine.- F. Epilogue.- References.- 6 Hepatitis and Polio Vaccines.- A. Introduction.- B. Hepatitis A Virus.- C. Hepatitis B Virus.- D. Hepatitis C Virus.- E. Hepatitis E Virus.- F. Poliovirus.- References.- 7 Herpes.- A. Herpesviridae.- B. Historical Background.- C. The Glycoproteins.- D. Early Events of Human Herpes Virus Replication.- E. Latency.- F. Reactivation.- G. Clinical Infections.- H. Immunology.- I. Therapeutic Vaccines.- J. Prophylactic Vaccines.- K. Conclusions.- References.- 8 Toxin-Based Vaccines (Diphtheria, Tetanus, Pertussis).- A. Introduction.- B. Diphtheria Toxin.- C. Tetanus Toxin.- D. Production, Effectiveness, and Problems of Conventional Diphtheria and Tetanus Vaccines.- E. Future Prospects.- F. Diphtheria and Tetanus Toxoids as Carriers for Polysaccharide Vaccines.- G. Pertussis.- References.- 9 Outer Membrane Protein Vaccines.- A. Introduction.- B. Neisseria gonorrhoeae.- C. Neisseria meningitidis.- D. Nontypable Haemophilus influenzae.- E. Moraxella catarrhalis.- F. Animal Models.- References.- 10 Carbohydrate-Based Bacterial Vaccines.- A. Introduction.- B. The Hib Experience.- C. Meningococcal Polysaccharide and Conjugate Vaccines.- D. Pneumococcal Polysaccharide and Conjugate Vaccines.- E. Salmonella, Shigella, and E. coli.- References.- 11 Mycobacteria.- A. Introduction.- B. The Cellular Response to Mycobacteria.- C. Mycobacterial Antigens.- D. Protection Versus Disease.- E. Mycobacterial Vaccines.- F. Future Prospects.- References.- 12 Vaccines Against Diarrheal Diseases.- A. Introduction.- B. Overview of the Main Diarrrheal Pathogens.- C. Mechanisms of Disease and Immunity in Diarrheal Diseases.- D. Cholera Vaccines.- E. ETEC Vaccines.- F. Shigella Vaccines.- G. Campylobacter jejuni Vaccines.- H. Rotavirus Vaccines.- References.- 13 Sexually Transmitted Diseases.- A. Introduction.- B. Special Challenges.- C. Gonorrhea.- D. Chlamydia Infection.- E. Genital Ulcers Caused by Haemophilus ducreyi.- F. Syphilis.- G. Human Genital Papilloma Virus Infection.- H. Herpes Simplex Infection.- I. Conclusion.- References.- 14 Designing a Vaccine Against HIV.- A. Perspective.- B. The Role of Antibody.- C. The Role of Cytotoxic T-Cells.- D. Other T-Cell Activities.- E. Mucosal Immunity.- F. Vaccine Approaches.- G. Prospectus.- References.- 15 An Overview of Malaria Vaccine Development Efforts.- A. Epidemiology.- B. The Parasite.- C. Approaches to Malaria Vaccine Development: Preventing Erythrocytic Stage Infection or Reducing Morbidity and Mortality Without Preventing Infection.- D. Preerythrocytic Stage Vaccines.- E. Erythrocytic Stage Vaccines: Reducing Parasite Burden and Blocking Pathogenesis.- F. Transmission Blocking Vaccines.- G. Conclusions.- References.- 16 Antifertility Vaccines.- A. Introduction.- B. Current Status of Vaccine Development.- C. Problems and Prospects.- References.- 17 Cancer Vaccines.- A. Introduction.- B. Tumor Antigens.- C. Types of Tumor Vaccines.- D. Downregulatory Mechanisms.- E. Conclusions and Outlook.- References.- 18 Prevention of Autoimmunity.- A. Overview of Autoimmune Diseases.- B. Autoreactive T Cells.- C. Antigen-Specific Therapy.- D.Future Directions.- References.- 19 Vaccines Against Allergies.- A. Introduction.- B. The Allergic Immune Response.- C. Traditional Immunotherapy.- D. Conclusions.- References.
Caracteristici
Provides a broad overview of how the immune system functions Presents the various forms of vaccines used against important infectious diseases